TitleComparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center (vol 20, pg e304, 2020)
AuthorsDou, Xuelin
Qin, Yazhen
Lai, Yueyun
Shi, Hongxia
Huang, Xiaojun
Jiang, Qian
AffiliationPeking Univ, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Inst Hematol,Natl Clin Res Ctr Hematol Dis, 11 Xizhimen South St, Beijing 100044, Peoples R China
Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
Chinese Acad Med Sci, Res Unit Key Tech Diag & Treatments Hematol Malig, Beijing, Peoples R China
Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
Issue DateJan-2021
PublisherCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
URIhttp://hdl.handle.net/20.500.11897/605758
ISSN2152-2650
DOI10.1016/j.clml.2020.10.011
IndexedSCI(E)
Appears in Collections:人民医院
生命科学学院

Files in This Work
There are no files associated with this item.

Web of Science®



Checked on Last Week

Scopus®



Checked on Current Time

百度学术™



Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.